Zichun Hua

8PUBLICATIONS
19CO-AUTHORS
Biologically active moleculesPredictive and prognostic markersAnalytical spectrometryCancer therapy (excl. chemotherapy and radiation therapy)Industrial microbiology (incl. biofeedstocks)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 18, 2026
Enantioselective Addition of Thiols to Pyrazolone Ketimines by Cinchona Alkaloid-Derived C-2' Amino Organocatalyst.

|Feb 13, 2026
Elovl6 inhibits colorectal cancer progression through stearic acid-mediated mitochondrial fusion and metabolic reprogramming.

Zhiqian Bi, Xiaoyao Chang, Shengyun Zhu

|Nov 14, 2025
From resistance to sensitivity: the impact of FADD and lncRNA PPFIA1-AS1 on cisplatin treatment in LUSC.

Xiaoyao Chang, Dangran Li, Yuanhao Tan

|Nov 07, 2025
Enantioselective α-Chlorination of β-Dicarbonyl Compounds by Isosteviol-Derived Sulfonamide Catalysts.

Tao Zhang, Shuman Zhai, Xiaoyu Du

|Jul 26, 2023
ADT-OH synergistically enhanced the antitumor activity of celecoxib in human colorectal cancer cells.

Huangru Xu, Ping Li, Hailin Ma

|Oct 25, 2022
FADD phosphorylation contributes to development of renal fibrosis by accelerating epithelial-mesenchymal transition.

Yan Lin, Fangfang Cai, Xiaoyang Wang

Pageof 2

Frequent Collaborators

3 joint publications

Hongqin Zhuang

2 joint publications

Yakun Wang

1 joint publications

Yan Lin

1 joint publications

Jia Liu